Indeed, poly-active molecules capable of mitigating brain free radical damage while enhancing acetylcholine signaling (via cholinesterase inhibition) are still being sought for combating Alzheimer’s disease (AD). This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.